Tsianakas, A. et al. 2019. Aprepitant in Anti-histamine-refractory Chronic Nodular Prurigo: A Multicentre, Randomized, Double-blind, Placebo-controlled, Cross-over, Phase-II trial (APREPRU). Acta Dermato-Venereologica. 99, 4 (Feb. 2019), 379–385. DOI:https://doi.org/10.2340/00015555-3120.